Atlas Trials

Olanzapine Plus Metoclopramide for the Prevention of Opioid-Induced Nausea and Vomiting

Clinical trial NCT07208305 · RECRUITING

Trial details

NCT number
NCT07208305
Sponsor
Affiliated Hospital of Qinghai University
Status
RECRUITING
Phase
Phase 3
Study type
INTERVENTIONAL
NauseaVomiting
Start date
2026-02-03
Primary completion
2027-12-30
Enrollment
222

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.